Commercial Spend Productivity study into the alcoholic drinks category in France
Using the Market Contact Audit® (MCA®), a tool offered by A&M analytics partner Integration, Alvarez & Marsal commissioned a high level MCA Calibration study for the Alcoholic Drinks category in France to understand how brands can win given the unique set of challenges in this market. It demonstrates the power of MCA both in relation to the alcoholic drinks category in particular and the consumer goods and services industry more generally.
The study covers speciality beers, whisky, vodka and rum and delivers insight into:
- What consumers need from brands
- How brands can maximise effectiveness, and where the opportunities are to drive growth
- Which activities build brands and deliver differentiation
- What role digital plays
- The contact activities that are key to win
Click here to view the full study
What next?
If you would like to know more, please get in touch. We would be delighted to provide further case studies on how MCA has delivered valuable insights to drive increased market share.
We can help you explore how Alvarez & Marsal’s distinctive approach to Commercial Spend Productivity can improve the performance of your brands and Sales and Marketing teams.
Section 232 Pharmaceutical Duties: UK Rate Cut to Zero, and the Origin and Section 301 Questions That Follow
August 5, 2026
Effective July 31, 2026, the additional Section 232 tariff on patented pharmaceuticals that are products of the United Kingdom was reduced from 10% to zero (heading 9903.04.63), implementing the U.S.–UK Pharmaceutical Pricing Arrangement. Because UK patented pharmaceuticals remain subject to Section 232 (at a 0% rate), they also fall within the Section 232 carve-out from the new Section 301 forced labor tariffs — so qualifying UK patented product should face no additional duty under either regime.
Enterprise Management Incentive Plans - Recent Changes and Common Pitfalls
August 5, 2026
Enterprise Management Incentive (EMI) option plans have been at the centre of UK employee incentivisation for many years and remain popular with privately owned, fast-growing companies.
Better Data, Better Exits: The New Playbook for Wealth and Insurance Platform Roll-Ups
August 5, 2026
There’s a new value creation imperative for private equity (PE) firms and corporates seeking to roll up financial technology (FinTech) and data platform acquisitions, especially in the extended higher interest rate environment. Many of the traditional value enhancement strategies still matter, but operational platforming—integrating tech, data, and systems—can be a defining competitive advantage in roll-ups.
Lee Health is Transforming Growth Into a Truly Integrated Health System
August 4, 2026
Healthcare transformation isn't just about growing. It's about creating a system where patients experience coordinated, seamless care.
